You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, December 2019
|
| DOI | 10.1186/s40425-019-0771-1 |
| Pubmed ID | |
| Authors |
Neil J. Shah, Ghassan Al-Shbool, Matthew Blackburn, Michael Cook, Anas Belouali, Stephen V. Liu, Subha Madhavan, Aiwu Ruth He, Michael B. Atkins, Geoffrey T. Gibney, Chul Kim |
X Demographics
The data shown below were collected from the profiles of 58 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 20 | 34% |
| Spain | 3 | 5% |
| Switzerland | 3 | 5% |
| United Kingdom | 3 | 5% |
| Canada | 2 | 3% |
| Japan | 2 | 3% |
| Italy | 2 | 3% |
| France | 1 | 2% |
| Belgium | 1 | 2% |
| Other | 4 | 7% |
| Unknown | 17 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 28 | 48% |
| Practitioners (doctors, other healthcare professionals) | 16 | 28% |
| Scientists | 11 | 19% |
| Science communicators (journalists, bloggers, editors) | 3 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 82 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 12 | 15% |
| Researcher | 12 | 15% |
| Student > Ph. D. Student | 10 | 12% |
| Student > Bachelor | 5 | 6% |
| Student > Master | 4 | 5% |
| Other | 9 | 11% |
| Unknown | 30 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 37% |
| Immunology and Microbiology | 6 | 7% |
| Biochemistry, Genetics and Molecular Biology | 4 | 5% |
| Agricultural and Biological Sciences | 3 | 4% |
| Unspecified | 1 | 1% |
| Other | 7 | 9% |
| Unknown | 31 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 64. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2022.
All research outputs
#668,885
of 25,540,105 outputs
Outputs from Journal for Immunotherapy of Cancer
#153
of 3,454 outputs
Outputs of similar age
#15,845
of 465,165 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#5
of 85 outputs
Altmetric has tracked 25,540,105 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,454 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 465,165 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.